[1]
van de Sande, M. , Tap, W.D., Gelhorn, H.L., Ye, X., Speck, R.M. , Palmerini, E., Stacchiotti, S., Desai, J., Wagner, A.J., Alcindor, T., Ganjoo, K., Martín-Broto, J. , Wang, Q. , Shuster, D., Gelderblom, H. and Healey, J.H. 2021. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. Acta Orthopaedica. 92, 4 (May 2021), 493–499. DOI:https://doi.org/10.1080/17453674.2021.1922161.